BioCentury
ARTICLE | Financial News

DecImmune Therapeutics financial update

October 4, 2010 7:00 AM UTC

DecImmune raised $1.1 million in an addition to a series A round, bringing the total raised in the round to $3.1 million. Astellas Venture; Amgen Ventures; and HealthCare Ventures participated. DecImm...